Studies have shown an improvement of endothelial dysfunction by enhancing NOS-III expression in a rat model of pulmonary hypertension and in apolipoprotein E (ApoE)–deficient mice [38, 39]. This evidence concerns the gene NOS3 and pulmonary hypertension.